1. Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08). (4th April 2018) Authors: Ruhstaller, T; Thuss-Patience, P; Hayoz, S; Schacher, S; Knorrenschild, J R; Schnider, A; Plasswilm, L; Budach, W; Eisterer, W; Hawle, H; Mariette, C; Hess, V; Mingrone, W; Montemurro, M; Girschikofsky, M; Schmidt, S C; Bitzer, M; Bedenne, L; Brauchli, P; Stahl, M Journal: Annals of oncology Issue: Volume 29:Number 6(2018) Page Start: 1386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O-010Cisplatin/5-fluorouracil +/- panitumumab for patients with non-resectable, advanced or metastatic esophageal squamous cell cancer: A randomized phase III AIO/EORTC trial with an extensive biomarker program. (20th June 2018) Authors: Moehler, M; Maderer, A; Thuss-Patience, P; Brenner, B; Hecker, J; Muñoz, F Longo; Meiler, J; Ettrich, T; Hofheinz, R; Al-Batran, S; Vogel, A; Mueller, L; Lutz, M; Borchert, K; Greil, R; Alsina, M; Karatas, A; Van Cutsem, E; Keller, R; Larcher-Senn, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Reply to the letter to the editor 'Anti-EGFR therapy in oesophagogastric cancer: precise but not enough' by M. Salati and S. Cascinu. (9th July 2018) Authors: Ruhstaller, T; Langer, R; Thuss-Patience, P; Eisterer, W; Stahl, M Journal: Annals of oncology Issue: Volume 29:Number 9(2018) Page Start: 2018 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗